Ciara Linnane on Muck Rack

Ciara Linnane

Brooklyn
As seen in: MSN, MSN Australia, MSN Canada, MSN Ireland, MSN Singapore, New York Post, The Wall Street Journal, The Wall Street Journal (China), Yahoo Finance, MarketWatch and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ciara

Contact Ciara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Genius Group Ltd.

|
By James Rogers , Tomi Kilgore , Ciara Linnane, Philip van Doorn
| MarketWatch
GCTK $9.95 70.67% 4.12 LMFA $3.85 19.23% 0.62 TELO $2.09 -8.33% -0.19 ITOS $10.30 0.39% 0.04
Open in Who Shared Issue with article?

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

|
By Ciara Linnane
| MarketWatch
Published: April 22, 2025 at 7:01 a.m. ET Quest Diagnostics Inc.’s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow. Secaucus, N.J.-based Quest DGX had adjusted per-share earnings of $2.21, up 8.3% from a year ago and ahead of the $2.15 FactSet consensus. Revenue rose 12.1% to $2.652 billion, also ahead of the $2.630 billion FactSet consensus.
Open in Who Shared Issue with article?

Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer

|
By Ciara Linnane
| MarketWatch
If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture Last Updated: April 18, 2025 at 11:55 a.m. ET First Published: April 17, 2025 at 7:15 a.m. ET Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form.
Open in Who Shared Issue with article?
See all 14,464 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Ciara

Contact Ciara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified